Physician profile
Darin Strako
NPI 1124124409
$1,183.80
in general payments reported to CMS, 2019-2025
15 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $35.81 · 2021: $325 · 2022: $34.31 · 2023: $20.32 · 2024: $200 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $492.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $398.20 | 2022-2025 | Tearcare System |
| Eyevance Pharmaceuticals LLC | $154.80 | 2021 | |
| Mallinckrodt Hospital Products INC. | $115.00 | 2021 | |
| Shire North American Group INC | $81.78 | 2019 | |
| Harrow Eye, LLC | $74.10 | 2024 | Vevye |
| Sun Pharmaceutical Industries INC. | $72.75 | 2019-2021 | |
| Allergan, INC. | $59.22 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $55.01 | 2019 | |
| Novartis Pharmaceuticals Corporation | $40.97 | 2019-2023 | |
| Kala Pharmaceuticals, INC. | $33.00 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $23.90 | 2019 | |
| Alcon Vision LLC | $21.46 | 2021 | |
| Lensar, INC. | $19.47 | 2019 | |
| Bausch & Lomb Americas INC. | $18.66 | 2024 | Xiidra, Miebo |
| Abbvie INC. | $15.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darin Strako listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.